Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$2.36 -0.14 (-5.61%)
(As of 11/15/2024 ET)

RMTI vs. FONR, EDAP, IRIX, ANGO, ARAY, RSLS, ABT, ISRG, SYK, and BSX

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include FONAR (FONR), Edap Tms (EDAP), IRIDEX (IRIX), AngioDynamics (ANGO), Accuray (ARAY), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Boston Scientific (BSX).

Rockwell Medical vs.

FONAR (NASDAQ:FONR) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.

FONAR has a net margin of 9.41% compared to Rockwell Medical's net margin of -1.25%. Rockwell Medical's return on equity of 8.55% beat FONAR's return on equity.

Company Net Margins Return on Equity Return on Assets
FONAR9.41% 6.10% 4.58%
Rockwell Medical -1.25%8.55%3.80%

Rockwell Medical received 128 more outperform votes than FONAR when rated by MarketBeat users. However, 74.69% of users gave FONAR an outperform vote while only 57.68% of users gave Rockwell Medical an outperform vote.

CompanyUnderperformOutperform
FONAROutperform Votes
180
74.69%
Underperform Votes
61
25.31%
Rockwell MedicalOutperform Votes
308
57.68%
Underperform Votes
226
42.32%

FONAR has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500.

Rockwell Medical has a consensus price target of $7.00, indicating a potential upside of 197.24%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts plainly believe Rockwell Medical is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

FONAR has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FONAR$102.88M0.92$10.57M$1.4010.74
Rockwell Medical$83.61M0.91-$8.44M-$0.05-47.10

In the previous week, Rockwell Medical had 16 more articles in the media than FONAR. MarketBeat recorded 21 mentions for Rockwell Medical and 5 mentions for FONAR. Rockwell Medical's average media sentiment score of 0.74 beat FONAR's score of 0.63 indicating that Rockwell Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FONAR
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rockwell Medical
5 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

50.6% of FONAR shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 2.2% of FONAR shares are held by insiders. Comparatively, 1.9% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

FONAR beats Rockwell Medical on 10 of the 19 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$76.11M$6.53B$5.15B$8.74B
Dividend YieldN/A8.16%5.18%4.08%
P/E Ratio-47.104.7865.5913.48
Price / Sales0.91377.381,278.7587.67
Price / Cash121.3251.2039.7035.24
Price / Book2.629.686.475.93
Net Income-$8.44M$154.43M$119.73M$225.73M
7 Day Performance-46.84%-9.46%-5.13%-1.34%
1 Month Performance-34.22%-7.27%-2.71%1.15%
1 Year Performance13.77%28.13%31.08%24.02%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
4.306 of 5 stars
$2.36
-5.6%
$7.00
+197.2%
+14.3%$76.11M$83.61M-47.10300Analyst Upgrade
News Coverage
Gap Down
FONR
FONAR
2.3415 of 5 stars
$15.85
+6.2%
N/A-10.7%$100.30M$102.88M10.36480Analyst Downgrade
Short Interest ↓
News Coverage
EDAP
Edap Tms
3.0541 of 5 stars
$2.55
+0.4%
N/A-47.9%$94.61M$65.42M-3.92307
IRIX
IRIDEX
0.7217 of 5 stars
$1.43
+0.0%
N/A-15.5%$23.61M$51.87M-2.17120Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
ANGO
AngioDynamics
4.7798 of 5 stars
$7.48
+0.5%
N/A-0.7%$303.94M$292.73M-1.23748Short Interest ↓
News Coverage
Positive News
ARAY
Accuray
4.6538 of 5 stars
$1.92
-3.0%
N/A-32.5%$193.09M$446.55M-11.29987Analyst Downgrade
RSLS
ReShape Lifesciences
0.3328 of 5 stars
$5.50
-2.8%
N/A-63.2%$2.81M$8.68M0.0050Short Interest ↑
News Coverage
Gap Down
ABT
Abbott Laboratories
4.9775 of 5 stars
$116.69
-0.1%
N/A+15.6%$202.39B$40.11B35.47114,000News Coverage
Positive News
ISRG
Intuitive Surgical
4.5875 of 5 stars
$533.46
-0.4%
N/A+73.6%$190.01B$7.12B85.7713,676Insider Selling
Short Interest ↑
News Coverage
Positive News
SYK
Stryker
4.9557 of 5 stars
$382.93
+1.1%
N/A+33.8%$145.98B$20.50B41.0452,000Analyst Upgrade
News Coverage
Positive News
BSX
Boston Scientific
4.4668 of 5 stars
$88.30
-0.2%
N/A+59.1%$130.14B$14.24B72.9848,000Short Interest ↑
News Coverage

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners